CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Cisplatin-Based Combination Chemotherapy for Advanced Hepatocellular Carcinoma: A Single Center Experience before the Sorafenib Era

Nae Yu Kim, Jong Mu Sun, Yu-Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jin-Wook Kim, Sook-Hyang Jeong, Jong Seok Lee

Cancer Research and Treatment. 2010;42(4):203-209. Published online 2010 December 31 DOI: https://doi.org/10.4143/crt.2010.42.4.203

Cisplatin-Based Combination Chemotherapy for Advanced Hepatocellular Carcinoma: A Single Center Experience before the Sorafenib Era

Nae Yu Kim, Jong Mu Sun, Yu-Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jin-Wook Kim, Sook-Hyang Jeong, Jong Seok Lee

Cancer Research and Treatment. 2010;42(4):203

Link1

Link2

Sorafenib-Regorafenib Sequential Therapy in Advanced Hepatocellular Carcinoma: A Single-Institute Experience

Kazuomi Ueshima, Naoshi Nishida, Masatoshi Kudo

Digestive Diseases. 2017;35(6):611-617

Link1 Link2

Combination of Matrine and Sorafenib Decreases the Aggressive Phenotypes of Hepatocellular Carcinoma Cells

Yan Lin, Lianjie Lin, Yu Jin, Ying Zhang, Dongxu Wang, Yue Tan, Changqing Zheng

Chemotherapy. 2014;60(2):112-118

Link1 Link2

Hepatocellular carcinoma: Sorafenib before liver transplantation?

Alain Braillon

Hepatology. 2009;51(6):2232-2233

Link1

Hepatic arterial infusion chemotherapy combined with sorafenib versus sorafenib monotherapy in advanced hepatocellular carcinoma: a systemic review and meta-analysis

Zhiyuan Yao, Anxin Chen, Mingyu Chen

Journal of Hepatology. 2020;73:S907-S908

Link1 Link2

Prospective Randomized Controlled Phase III Trial Comparing the Efficacy of Sorafenib versus Sorafenib in Combination with Low-Dose Cisplatin/Fluorouracil Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma

M. Kudo, K. Ueshima, O. Yokosuka, S. Obi, N. Izumi, H. Aikata, H. Nagano, E. Hatano, Y. Sasaki, K. Hino, T. Kumada, K. Yamamoto, Y. Imai, S. Iwadou, C. Ogawa, T. Okusaka, Y. Arai, F. Kanai, K. Akazawa

Journal of Hepatology. 2016;64(2):S209-S210

Link1 Link2

Mitomycin C, teniposide, and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung

Lung Cancer. 1991;7(6):397

Link1 Link2

Sorafenib plus cisplatin for hepatocellular carcinoma

Vicki Brower

The Lancet Oncology. 2016;17(10):e424

Link1 Link2

Efficacy and safety of sorafenib in combination with gemcitabine in patients with advanced hepatocellular carcinoma: A multicenter, open-label, single-arm phase II study

Vichien Srimuninnimit, Virote Sriuranpong, Suthida Suwanvecho

Asia-Pacific Journal of Clinical Oncology. 2014;10(3):255-260

Link1

Sorafenib for Egyptian patients with advanced hepatocellular carcinoma; single center experience

Omar Abdel-Rahman, Manal Abdelwahab, Mohammed Shaker, Sherif Abdelwahab, Mohammed Elbassiony, Mahmoud Ellithy

Journal of the Egyptian National Cancer Institute. 2014;26(1):9-13

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.